2024-04-24  10:00:00 PM Chg. -1.0000 Volume Bid10:00:00 AM Ask10:00:00 AM Market Capitalization Dividend Y. P/E Ratio
27.4300USD -3.52% 486,690
Turnover: 7.72 mill.
26.0600Bid Size: 200 29.8800Ask Size: 400 1.26 bill.USD - -

Business description

Since 1992, Omnicell (NASDAQ: OMCL) has been creating innovative solutions to improve patient care, anywhere it is delivered. Omnicell is a leading supplier of comprehensive automation and business analytics software for medication and supply management across the entire health care continuum—from the acute care hospital setting, to post-acute skilled nursing and long-term care facilities, to the patient's home.
 

Management board & Supervisory board

CEO
Randall A. Lipps
Management board
Peter Kuipers, Christine Mellon, Dan S. Johnston, Scott Seidelmann
Supervisory board
Randall A. Lipps, Bruce D. Smith, Bruce E. Scott, James T. Judson, Joanne Bauer, Mark Parrish, Robin G. Seim, Sara J. White, Vance Moore
 

Company data

Name: Omnicell Inc.
Address: 590 East Middlefield Road,Mountain View, California 94043-4008, USA
Phone: +1-650-251-6100
Fax: +1-650-251-6266
E-mail: -
Internet: www.omnicell.com/
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12-31
Free Float: 68.17%
IPO date: -

Investor relations

Name: Kathleen Nemeth
IR phone: -
IR Fax: -
IR e-mail: ir@omnicell.com

Company calendar

CW 18 | 2024-05-02 Interim Report 1st Quarter/3 Months
 

Main Shareholders

Freefloat
 
68.17%
BlackRock Inc. Inc.
 
15.47%
The Vanguard Group, Inc.
 
10.43%
Wellington Management Group LLP
 
5.93%